NO20031096L - Forbedret bioaktivt myseprotein-hydrolysat - Google Patents

Forbedret bioaktivt myseprotein-hydrolysat

Info

Publication number
NO20031096L
NO20031096L NO20031096A NO20031096A NO20031096L NO 20031096 L NO20031096 L NO 20031096L NO 20031096 A NO20031096 A NO 20031096A NO 20031096 A NO20031096 A NO 20031096A NO 20031096 L NO20031096 L NO 20031096L
Authority
NO
Norway
Prior art keywords
whey protein
protein hydrolyzate
enhanced bioactive
bioactive whey
enhanced
Prior art date
Application number
NO20031096A
Other languages
English (en)
Other versions
NO326072B1 (no
NO20031096D0 (no
Inventor
Ralf-Christian Schlothauer
Linda May Schollum
Julian Robert Reid
Stephanie Adele Harvey
Alistair Carr
Rachel Lois Fanshawe
Original Assignee
New Zealand Dairy Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Zealand Dairy Board filed Critical New Zealand Dairy Board
Publication of NO20031096D0 publication Critical patent/NO20031096D0/no
Publication of NO20031096L publication Critical patent/NO20031096L/no
Publication of NO326072B1 publication Critical patent/NO326072B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20031096A 2000-09-11 2003-03-10 Myseprotein-hydrolysat, fremgangsmate for dets fremstilling, farmasoytisk sammensetning, matprodukt samt anvendelse. NO326072B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ506866A NZ506866A (en) 2000-09-11 2000-09-11 Bioactive whey protein hydrolysate free of bitter flavours wherein the enzyme used is a heat labile protease
PCT/NZ2001/000188 WO2002019837A1 (en) 2000-09-11 2001-09-11 Improved bioactive whey protein hydrolysate

Publications (3)

Publication Number Publication Date
NO20031096D0 NO20031096D0 (no) 2003-03-10
NO20031096L true NO20031096L (no) 2003-05-07
NO326072B1 NO326072B1 (no) 2008-09-15

Family

ID=19928101

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031096A NO326072B1 (no) 2000-09-11 2003-03-10 Myseprotein-hydrolysat, fremgangsmate for dets fremstilling, farmasoytisk sammensetning, matprodukt samt anvendelse.

Country Status (18)

Country Link
EP (1) EP1317186B1 (no)
JP (1) JP2004508025A (no)
KR (1) KR100845362B1 (no)
CN (1) CN1229031C (no)
AT (1) ATE494795T1 (no)
AU (2) AU2001290376B2 (no)
BR (1) BR0113812A (no)
CA (1) CA2421714A1 (no)
DE (1) DE60143846D1 (no)
DK (1) DK1317186T3 (no)
ES (1) ES2359789T3 (no)
HU (1) HUP0302370A2 (no)
MX (1) MXPA03002109A (no)
NO (1) NO326072B1 (no)
NZ (1) NZ506866A (no)
PE (1) PE20030289A1 (no)
WO (1) WO2002019837A1 (no)
ZA (1) ZA200301982B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244567A1 (en) 2002-07-29 2005-11-03 Aminotech As Method for production of peptides/amino acids produced by said method and use of the same
TWI317636B (en) * 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
US7399496B2 (en) * 2003-02-07 2008-07-15 Glanbia Nutritionals (Ireland) Limited Hydrolyzed whey protein compositions
EP1568707A1 (en) * 2004-02-26 2005-08-31 Puleva Biotech, S.A. Antihypertensive peptides from casein hydrolysates
CN100415768C (zh) * 2004-11-29 2008-09-03 中国农业大学 乳清蛋白酶法生产血管紧张素转化酶(ace)抑制肽的方法
US20100056458A1 (en) * 2005-06-30 2010-03-04 Campina Nederland Holding B.V. Peptides Inhibiting Angiotensin-Converting Enzyme
EP1998637A1 (en) * 2006-03-24 2008-12-10 Unilever N.V. Healthy food product
US9662368B2 (en) * 2006-06-15 2017-05-30 Murray Goulburn Co-Operative., Limited Formulation comprising whey protein and hydrolysates for improving muscle recovery
EP1967524A1 (en) * 2007-03-06 2008-09-10 Friesland Brands B.V. Methods for producing ACE-inhibitory peptides from whey and peptides obtained thereby
WO2009097541A1 (en) * 2008-02-01 2009-08-06 Rich Products Corporation Foam compositions
DE102008032828A1 (de) * 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
US9055752B2 (en) 2008-11-06 2015-06-16 Intercontinental Great Brands Llc Shelf-stable concentrated dairy liquids and methods of forming thereof
CN101736067B (zh) * 2010-01-08 2012-04-18 中国农业大学 一种乳清蛋白降血压肽及其制备方法与应用
CN101829316B (zh) * 2010-04-30 2012-07-11 中国人民解放军总医院 一种乳清蛋白水解物及其在制备降糖药物中的用途
UA112972C2 (uk) 2010-09-08 2016-11-25 Інтерконтінентал Грейт Брендс ЛЛС Рідкий молочний концентрат з високим вмістом сухих речовин
US20140011742A1 (en) * 2010-12-09 2014-01-09 Mcgill University Bioactive Peptides and Proteins Containing Bioactive Peptides, their Uses and Processes for Making the Same
JP5892687B2 (ja) 2011-07-07 2016-03-23 高砂香料工業株式会社 風味改善ペプチド
CN103695518B (zh) * 2013-12-30 2016-04-06 东北农业大学 利用乳清蛋白肽降低血清胆固醇水平的产品和制备方法
US10639334B2 (en) * 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
CN103805664B (zh) * 2014-03-06 2017-04-05 渤海大学 一种低敏性糖基化乳清蛋白水解物及其制备方法
WO2015169928A1 (en) * 2014-05-07 2015-11-12 Nestec S.A. Foamable dairy product
BR112016027871A2 (pt) * 2014-06-16 2017-10-24 Kirin Kk composição para melhorar a memória, a função de aprendizado e/ou função cognitiva
JP6262694B2 (ja) * 2014-08-18 2018-01-17 森永乳業株式会社 プロリルオリゴペプチダーゼ阻害剤
ES2837050T3 (es) 2015-10-01 2021-06-29 Frieslandcampina Nederland Bv Composición nutricional líquida que comprende caseína micelar y proteína de suero de leche hidrolizada
CN108137650B (zh) * 2015-11-16 2022-04-08 麒麟控股株式会社 肽组合物及其制造方法
ES3071657T3 (en) 2015-12-18 2026-06-24 Nestle Sa Heat sterilized high protein compositions with hydrolyzed protein from a continuous process with at least one endopeptidase
CN107136295B (zh) * 2016-03-01 2021-07-27 内蒙古伊利实业集团股份有限公司 一种部分水解乳清蛋白粉及其制备方法
CN107814836A (zh) * 2017-12-01 2018-03-20 浙江熊猫乳业集团股份有限公司 一种生物活性多肽fpgpipns及其制备方法和应用
CN107858394B (zh) * 2017-12-25 2021-09-07 内蒙古蒙牛乳业(集团)股份有限公司 乳清蛋白水解产物的制备方法
CN118556752A (zh) 2019-05-29 2024-08-30 阿拉食品公司 适口的深度水解乳清蛋白水解物
CN113061175B (zh) * 2020-12-17 2023-04-21 西北民族大学 以曲拉为原料制备的钙共沉淀蛋白及其制备方法
CN114457137B (zh) * 2022-01-12 2024-05-24 广州舜康生物科技有限公司 一种连续循环水解并精准筛选肽分子量的深度水解乳清蛋白的制备方法
CN115669945B (zh) * 2022-10-24 2024-03-08 上海艾斯顿医疗科技有限公司 一种具有神经营养作用的脂质体包裹多肽及制备方法和应用
CN120569136A (zh) * 2023-02-14 2025-08-29 森永乳业株式会社 抗肥胖用组合物
KR102740503B1 (ko) * 2024-02-14 2024-12-11 (주)네오크레마 유청단백질 가수분해물 또는 유청단백질 가수분해물 유래 펩타이드를 포함하는 퇴행성 신경 질환 치료용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK589785A (da) * 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
SE459140B (sv) * 1986-11-25 1989-06-12 Albuglobe Ab Hydrolys av vassleprotein foer att underlaetta avskiljning av fett daerifraan
EP0518999B1 (en) * 1990-03-09 1995-08-30 Novo Nordisk A/S Protein hydrolysates
DK0588841T3 (da) 1991-05-31 1997-05-12 Danmark Protein As Fremgangsmåde til fremstilling af et valleproteinhydrolysat
AU2468292A (en) * 1991-08-30 1993-04-05 Teagasc, The Agriculture And Food Development Authority Hypoallergenic whey protein hydrolysate
DK71292D0 (no) * 1992-05-27 1992-05-27 Novo Nordisk As
JP3059595B2 (ja) * 1992-11-20 2000-07-04 森永乳業株式会社 沈澱を生じない乳清蛋白質分解物の製造法
DK0799577T3 (da) * 1994-10-14 2001-06-18 Morinaga Milk Industry Co Ltd Peptidblanding og produkter deraf
JPH11509727A (ja) * 1995-06-30 1999-08-31 エムディ フーズ エイ.エム.ビィ.エイ. ペプチド混合物の製法
JPH1033115A (ja) * 1996-07-24 1998-02-10 Nouchikusangiyou Shinko Jigyodan ホエー飲料とその製造法
DE69920219T2 (de) * 1998-06-17 2005-09-22 New Zealand Dairy Board Bioaktive molke-eiweisshydrolysate
MY129566A (en) * 1999-01-19 2007-04-30 Nestle Sa A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance

Also Published As

Publication number Publication date
NZ506866A (en) 2003-05-30
PE20030289A1 (es) 2003-03-25
CN1474656A (zh) 2004-02-11
MXPA03002109A (es) 2004-05-24
BR0113812A (pt) 2005-02-01
NO326072B1 (no) 2008-09-15
ZA200301982B (en) 2004-06-25
NO20031096D0 (no) 2003-03-10
EP1317186A1 (en) 2003-06-11
WO2002019837A1 (en) 2002-03-14
DE60143846D1 (de) 2011-02-24
ATE494795T1 (de) 2011-01-15
HK1063132A1 (en) 2004-12-17
KR100845362B1 (ko) 2008-07-09
AU2001290376B2 (en) 2005-08-25
KR20030046442A (ko) 2003-06-12
HUP0302370A2 (hu) 2003-10-28
EP1317186A4 (en) 2006-04-19
AU9037601A (en) 2002-03-22
CN1229031C (zh) 2005-11-30
DK1317186T3 (da) 2011-05-02
JP2004508025A (ja) 2004-03-18
ES2359789T3 (es) 2011-05-26
CA2421714A1 (en) 2002-03-14
EP1317186B1 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
DK1317186T3 (da) Forbedret bioaktivt valleproteinhydrolysat
JP2001515920A5 (no)
MY132120A (en) Bone health compositions derived from milk.
GB0126194D0 (en) Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
DK1383397T3 (da) Aromakoncentrater
DK1095061T3 (da) Peptider baseret på sekvensen af humant lactoferring og deres anvendelse
DE60126933D1 (de) Verfahren zur fermentativen herstellung von l-threonine
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
CA2567582A1 (en) Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates
WO2002100895A3 (de) Antimikrobiell wirkendes peptid
EP1264838A4 (en) PROTEIN HYDROLYSATES, THEIR PRODUCTION PROCESS AND FOOD AND DRINKS CONTAINING PROTEIN HYDROLYSTS
ATE279931T1 (de) Verwendung von enzymatischen austerfleischhydrolysaten zur herstellung von antiradikalischen zusammensetzungen
WO2002046211A3 (en) Peptides derived from colostrinin
DE50213015D1 (de) Lipase-varianten
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
ITTO20000674A0 (it) Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca.
WO2001053347A3 (fr) Gene nphs2 implique dans le syndrome nephrotique cortico-resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques
HK1046852A1 (zh) 用熱震蛋白質令細胞產生更多化學激活素
MY134713A (en) Improved bioactive whey protein hydrolysate.
MX2007003149A (es) Metodo para desaborizar materiales derivados de soja usando electrodialisis.
DE50110117D1 (de) Lineare Polydialkylorganosiloxane mit Polyoxyalkylen- und aminofunktionellen Gruppen, die zusätzlich endständige Alkoxygruppen aufweisen
WO2004020466A8 (en) Protein tyrosine phosphatase inhibitors
DE60332730D1 (de) Molkenproteinhydrolysate
WO2004000870A3 (en) Two synthetic peptides for treatment and prevention of cancers
WO2001055209A3 (en) Novel human septin and uses thereof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees